Woiwode Thomas

CIK 00016192947 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001619294

Recent Transactions

50 trades

Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2023-05-25+24,000→ 24,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-06-23+15,000→ 15,000 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (Right to Buy)
2022-06-17+3,500→ 3,500 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2022-05-26+24,000→ 24,000 total
Purchase
Tempest Therapeutics, Inc.$TPST
Common Stock
2022-04-29$2.36/sh+2,118,644→ 2,118,644 total
Other
Gritstone bio, Inc.
Common Stock
2021-08-25−6,612→ 0 total
Other
Gritstone bio, Inc.
Common Stock
2021-08-25+6,668→ 6,668 total
Other
Gritstone bio, Inc.
Common Stock
2021-08-25−6,668→ 0 total
Other
Gritstone bio, Inc.
Common Stock
2021-08-25−444,744→ 902,965 total
Other
Gritstone bio, Inc.
Common Stock
2021-08-25+128→ 128 total
Other
Gritstone bio, Inc.
Common Stock
2021-08-25+6,612→ 6,612 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (Right to Buy)
2021-07-01+6,635→ 6,635 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (Right to Buy)
2021-07-01+6,635→ 6,635 total
Award
Tempest Therapeutics, Inc.$TPST
Common Stock
2021-06-25+7,377→ 7,377 total
Award
Tempest Therapeutics, Inc.$TPST
Common Stock
2021-06-25+997,940→ 997,940 total
Award
Tempest Therapeutics, Inc.$TPST
Common Stock
2021-06-25+1,171,094→ 1,171,094 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2021-06-17+15,000→ 15,000 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-06-11−9,719→ 0 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-06-11−485,979→ 1,457,937 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-06-11+8,383→ 8,383 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-06-11+2,226→ 4,452 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-06-11+9,719→ 9,719 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-06-11−8,383→ 0 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2021-05-27+16,918→ 16,918 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2021-05-12+40,000→ 40,000 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-04-26+9,720→ 9,720 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-04-26+2,226→ 2,226 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-04-26−9,720→ 0 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-04-26−485,979→ 1,943,916 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-04-26+8,385→ 8,385 total
Other
Aligos Therapeutics, Inc.$ALGS
Common Stock
2021-04-26−8,385→ 0 total
Purchase
Gritstone bio, Inc.
Common Stock
2020-12-30$3.71/sh+1,347,709→ 1,347,709 total
Other
Adverum Biotechnologies, Inc.
Common Stock
2020-12-14+12,783→ 18,822 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-1 Preferred Stock
2020-10-20−463,959→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series A Preferred Stock
2020-10-20−2,145,991→ 0 total
Purchase
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20$15.00/sh+200,000→ 862,444 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+463,959→ 463,959 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+2,145,991→ 2,145,991 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-2 Preferred Stock
2020-10-20−85,065→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+198,485→ 662,444 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+198,839→ 2,344,830 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-1 Preferred Stock
2020-10-20−198,839→ 0 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Common Stock
2020-10-20+85,065→ 2,429,895 total
Conversion
Aligos Therapeutics, Inc.$ALGS
Series B-2 Preferred Stock
2020-10-20−198,485→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-23+30,000→ 30,000 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2020-06-18+12,500→ 12,500 total
Conversion
Passage BIO, Inc.$PASG
Series B Preferred Stock
2020-03-03−708,352→ 0 total
Conversion
Passage BIO, Inc.$PASG
Common Stock
2020-03-03+1,049,175→ 4,026,417 total
Purchase
Passage BIO, Inc.$PASG
Common Stock
2020-03-03$18.00/sh+225,000→ 933,352 total
Conversion
Passage BIO, Inc.$PASG
Series A-2 Preferred Stock
2020-03-03−1,049,175→ 0 total

Companies

Recent Filings

Address

C/O ADVERUM BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE

MENLO PARK, CA, 94025

View on SEC.gov